Prescription Information Modernization Act of 2025

This bill moves the detailed “package insert” for prescription drugs to a digital format. Drug companies could share the official prescribing information online instead of always putting paper leaflets in every package. Doctors and pharmacists must still be able to choose paper, either regularly or as needed, and companies must send it quickly at no extra cost. The Department of Health and Human Services will issue rules within a year to explain how this works and how health care professionals can request paper copies directly from manufacturers or distributors, while trying to avoid extra costs for clinics and pharmacies.

A public workshop will be held within two years to improve how this information is shown and accessed. The change takes effect for drugs entering the market on the earlier of two dates: two years after the law is enacted or when the final rules take effect.

• Who is affected: Drug makers, doctors, and pharmacists; patients indirectly through how information is shared.
• What changes: Prescribing info can be digital-only, but paper must be available on request at no cost, and rules will guide access and keep burdens low.
• When: Rules due within 1 year; a public workshop within 2 years; the digital option starts by the earlier of 2 years after enactment or when the rules take effect.